免疫製剤を含む脳梗塞治療用医薬品組成物
- 专利权人:
- 国立大学法人;新潟大学
- 发明人:
- 下畑 享良
- 申请号：
- JP2010124374
- 公开号：
- JP5823671B2
- 申请日:
- 2010.05.31
- 申请国别(地区):
- JP
- 年份:
- 2015
- 代理人:
- 摘要：
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for the treatment of cerebral infarction, administrable even to a patient after cerebral infarction acute stage passage.
SOLUTION: The therapeutic pharmaceutical composition for the treatment of cerebral infarction comprises a thrombolytic agent and a binding inhibitor for inhibiting the binding of a vascular endothelial growth factor (VEGF) to a receptor of VEGF. The therapeutic pharmaceutical composition for the treatment of cerebral infarction is, if necessary, administered to patients after cerebral infarction acute stage passage. The therapeutic pharmaceutical composition for the treatment of cerebral infarction, if necessary, contains tissue type plasminogen-activator (t-PA) or its derivative. The therapeutic pharmaceutical composition for the treatment of cerebral infarction, if necessary, contains an anti-VEGF-A neutralizing antibody or a derivative thereof.
COPYRIGHT: (C)2011,JPO&INPIT
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- 免疫製剤を含む脳梗塞治療用医薬品組成物
- 免疫製剤を含む脳梗塞治療用医薬品組成物
- COMBINED MESENCHYMAL STEM CELL TRANSPLANTATION AND TARGETED DELIVERY OF VEGF FOR TREATMENT OF MYOCARDIAL INFARCTION
- Pharmaceutical compositions comprising peptide antagonists of vascular endothelial growth factor
- TUMOR THERAPY WITH AN ANTIBODY FOR VASCULAR ENDOTHELIAL GROWTH FACTOR AND AN ANTIBODY FOR HUMAN EPITHELIAL GROWTH FACTOR RECEPTOR TYPE 2
